Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Sales (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Return on Sales for 16 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 16.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.66% through Dec 2025, down 53.0% year-over-year, with the annual reading at 0.66% for FY2025, 53.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.14% at Harvard Bioscience, down from 0.06% in the prior quarter.
  • The five-year high for Return on Sales was 0.08% in Q2 2022, with the low at 2.31% in Q1 2025.
  • Average Return on Sales over 5 years is 0.18%, with a median of 0.06% recorded in 2023.
  • The sharpest move saw Return on Sales rose 26bps in 2023, then tumbled -212bps in 2025.
  • Over 5 years, Return on Sales stood at 0.02% in 2021, then tumbled by -428bps to 0.06% in 2022, then rose by 4bps to 0.06% in 2023, then soared by 124bps to 0.01% in 2024, then tumbled by -1163bps to 0.14% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.14%, 0.06%, and 0.11% for Q4 2025, Q3 2025, and Q2 2025 respectively.